These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19270204)

  • 1. Insulin resistance and glucose homeostasis in peritoneal dialysis.
    Fortes PC; de Moraes TP; Mendes JG; Stinghen AE; Ribeiro SC; Pecoits-Filho R
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S145-8. PubMed ID: 19270204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing cardiometabolic risk in peritoneal dialysis patients: role of the dialysis solution.
    Holmes CJ
    J Diabetes Sci Technol; 2009 Nov; 3(6):1472-80. PubMed ID: 20144403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic impact of peritoneal dialysis.
    de Moraes TP; Pecoits-Filho R
    Contrib Nephrol; 2009; 163():117-123. PubMed ID: 19494604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis.
    García-López E; Carrero JJ; Suliman ME; Lindholm B; Stenvinkel P
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S205-9. PubMed ID: 17556305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic consequences of peritoneal dialysis treatment.
    Gallieni M; Musetti C; Granata A; Olivi L; Bertoli S
    Panminerva Med; 2009 Sep; 51(3):175-85. PubMed ID: 19859052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of systemic glucose absorption with peritoneal dialysis: how good is the evidence?
    Mehrotra R; de Boer IH; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):663-8. PubMed ID: 24076559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of metabolic syndrome in peritoneal dialysis.
    Park SH; Lindholm B
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S137-44. PubMed ID: 19270203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins for treatment of dyslipidemia in chronic kidney disease.
    Shurraw S; Tonelli M
    Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin in children on peritoneal dialysis: relationship to insulin resistance and nutritional status.
    Kamariski M; Biscardi M; Cestino L; Miatello R; Guntsche E; Valles PG
    Nephron Clin Pract; 2009; 113(1):c24-32. PubMed ID: 19590232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients.
    Jegatheesan D; Cho Y; Johnson DW
    Semin Nephrol; 2018 May; 38(3):277-290. PubMed ID: 29753403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis.
    Park JT; Chang TI; Kim DK; Choi HY; Lee JE; Kim HW; Chang JH; Park SY; Kim E; Yoo TH; Han DS; Kang SW
    Metabolism; 2009 Oct; 58(10):1379-85. PubMed ID: 19501862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammation in peritoneal dialysis: the search for the holy grail?
    Pecoits-Filho R; Stenvinkel P; Wang AY; Heimbürger O; Lindholm B
    Perit Dial Int; 2004; 24(4):327-39. PubMed ID: 15335146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis and cardiovascular disease.
    Balafa O; Krediet RT
    Minerva Urol Nefrol; 2012 Sep; 64(3):153-62. PubMed ID: 22971680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dyslipidemia in patients being treated with peritoneal dialysis].
    Zharfbin A
    Vnitr Lek; 2006 Nov; 52(11):1051-7. PubMed ID: 17165524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between insulin resistance and the development of cardiovascular disease.
    Ormazabal V; Nair S; Elfeky O; Aguayo C; Salomon C; Zuñiga FA
    Cardiovasc Diabetol; 2018 Aug; 17(1):122. PubMed ID: 30170598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated analysis of estimated insulin resistance using the HOMAIR index in nondiabetic patients on peritoneal dialysis and its relationship with cardiovascular disease and mortality.
    Sánchez-Villanueva R; Estrada P; del Peso G; Grande C; Díez JJ; Iglesias P; González E; Aguilar-Rodríguez A; Selgas R; Bajo MA; ;
    Nefrologia; 2013 Jan; 33(1):85-92. PubMed ID: 23364630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy].
    Wesołowski P; Saracyn M; Nowak Z; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):359-63. PubMed ID: 18634374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling inflammation in peritoneal dialysis: the role of pd-related factors as potential intervention targets.
    Fortes PC; Versari PH; Stinghen AE; Pecoits-Filho R
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S76-81. PubMed ID: 17556335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solutes transport characteristics in peritoneal dialysis: variations in glucose and insulin serum levels.
    da Silva DR; Figueiredo AE; Antonello IC; Poli de Figueiredo CE; d'Avila DO
    Ren Fail; 2008; 30(2):175-9. PubMed ID: 18300117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between smoking habits and the features of the metabolic syndrome in a non-diabetic population.
    Masulli M; Riccardi G; Galasso R; Vaccaro O
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):364-70. PubMed ID: 16829345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.